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Fig. 1.
Clinical presentation of a basal cell carcinoma from our series. tumours were diagnosed as lymphomas, either primitively cutaneous or secondarism (n = 5), eccrine syringofibroadenomas (n = 2), fibroadenomas (n = 2), and porocarcinoma (n = 1). Chronic LUs represent an increasing health burden, and there is consensus on performing skin biopsies for histopathologic examination of these lesions [3] [4] [5] . We suggest analyzing at least two samples from each lesion: of the edge and the bed of the LU. A 3-mm punch is a safe and effective tool for this purpose: no evidence of worsening has been described for any lesion undergoing this procedure, while interestingly some cases seem to benefit from the biopsy itself as it stimulates local healing [4] . The Food and Drug Administration recommends wound biopsy as a fundamental tool to detect neoplastic, immune-mediated, or infectious diseases [6] . Our experience confirms that neoplasms, in particular non-melanoma skin cancers, represent a consistent proportion of chronic LUs [7] . Emerging authors have focused on the role of chronic venous ulceration in triggering the development of basal cell carcinomas [5, 7, 8] . On the other hand, neoplastic lesions can become chronically ulcerated, for example in Marjolin ulcer, or also show ulceration from their appearance [9, 10] . In addition, ulceration is a negative prognostic factor in cutaneous neoplasms, which often present a high metastatic rate; therefore, biopsy appears even more important in these cases [9] . 
